LifeVantage Co. (NASDAQ:LFVN – Get Free Report) declared a quarterly dividend on Wednesday, February 5th,RTT News reports. Investors of record on Monday, March 3rd will be paid a dividend of 0.04 per share on Monday, March 17th. This represents a $0.16 dividend on an annualized basis and a yield of 0.70%.
LifeVantage has a payout ratio of 15.4% meaning its dividend is sufficiently covered by earnings.
LifeVantage Price Performance
Shares of NASDAQ:LFVN traded down $1.00 during trading on Wednesday, hitting $22.74. 486,894 shares of the company were exchanged, compared to its average volume of 270,076. The firm’s 50 day moving average price is $18.97 and its 200-day moving average price is $13.59. LifeVantage has a 12-month low of $5.22 and a 12-month high of $27.38. The stock has a market capitalization of $284.70 million, a P/E ratio of 71.06 and a beta of 0.84.
Wall Street Analyst Weigh In
LFVN has been the topic of a number of research reports. Craig Hallum initiated coverage on LifeVantage in a research note on Tuesday, January 14th. They set a “buy” rating and a $35.00 price target on the stock. Lake Street Capital initiated coverage on shares of LifeVantage in a research report on Thursday, December 19th. They set a “buy” rating and a $26.00 target price on the stock.
Check Out Our Latest Research Report on LFVN
LifeVantage Company Profile
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.
Featured Stories
- Five stocks we like better than LifeVantage
- Where Do I Find 52-Week Highs and Lows?
- 3 Must-Have ETFs Set to Dominate This Quarter
- What Investors Need to Know to Beat the Market
- Seeking Stability? These 3 Stocks Offer Strong Potential
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Trade War Bargain Stocks: Top 3 Picks Too Good to Pass Up
Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.